cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.21118807.v1
title: Supplementary Material for: Relationship between <b><i>Blastocystis</i></b> spp. with Accompanying Food Hypersensitivity and Chronic Spontaneous Urticaria

description: <b><i>Introduction:</i></b> The relationship between <i>Blastocystis</i> spp. and chronic spontaneous urticaria (CSU) is unclear. The aim of this study was to evaluate the role of this parasitic infection on CSU and to search for risky groups in CSU patients with this parasite. <b><i>Methods:</i></b> Seventy adult CSU patients with <i>Blastocystis</i> spp. in their stool samples forming Group A and 70 CSU patients without any parasite as Group B were prospectively compared regarding urticaria activity score-7 (UAS7), medication scores (MS), and laboratory parameters. All patients received CSU treatment, and additionally, those in group A received an antiparasitic antibiotic. Eight months later, the same parameters were compared between the ones in remission (group A1) and those still having CSU symptoms (group A2) in group A. <b><i>Results:</i></b> UAS7 and MS were lower in group A than in group B (<i>p</i>: 0.007, <i>p</i> &lt; 0.001) 8 months later, while the initial scores were similar. The presence of food hypersensitivity reactions (FHRs) was higher in group A than in group B (<i>p</i> &lt; 0.001) and was detected as a significant risk factor in the presence of <i>Blastocystis</i> spp. infection (<i>p</i>: 0.002, OR [CI] = 0.151 [0.045–0.502]). In group A, UAS7, MS, serum total IgE levels, and blood eosinophil counts decreased 8 months later (<i>p</i> &lt; 0.001, <i>p</i> &lt; 0.001, <i>p</i>: 0.003, <i>p</i>: 0.004, respectively). Additionally, total IgE levels and eosinophil counts decreased in group A1 (<i>p</i>: 0.033, <i>p</i>: 0.002) while they did not change in group A2. <b><i>Discussion/Conclusion:</i></b> The eradication of <i>Blastocystis</i> spp. can improve the disease activity in CSU and the presence of FHRs seems to be risky in CSU patients with <i>Blastocystis</i> spp.
DOI: 10.6084/m9.figshare.21118450.v1
title: Supplementary Material for: Risk Factors for Immune Checkpoint Inhibitor-Related Pneumonitis in Cancer Patients: A Systemic Review and Meta-Analysis

description: <b><i>Background:</i></b> Immune checkpoint inhibitors (ICIs) can lead to one of the common and quite serious immune-related adverse events (irAEs) in a real-world setting, namely, checkpoint inhibitor pneumonitis (CIP). <b><i>Objective:</i></b> We aimed to investigate the potential risk factors for CIP in cancer patients treated by ICIs and quantify the association. <b><i>Methods:</i></b> We conducted a systematic literature review in PubMed, EMBASE, and Web of Science from January 1, 2000, to March 20, 2022, with no study design restrictions. Studies evaluating the risk factors for CIP in cancer patients treated with ICIs-containing regimes were included. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for risk factors of CIP by using random-effect model. Heterogeneity was assessed by sensitivity analysis and subgroup analysis regarding CIP severity, geographical regions, cancer types, treatment regimes, and ICI types. <b><i>Results:</i></b> A total of 35 studies comprising 142,703 patients were eventually included. The incidence of grade I–V and grade III–V CIP in cancer patients was 0.16 (95% CI: 0.14–0.18) and 0.06 (95% CI: 0.05–0.08), respectively. When combining the adjusted ORs, the following risk factors were significantly associated with the development of CIP: squamous cell carcinoma (OR: 1.31, 95% CI: 1.18–1.45), previous thoracic radiotherapy (OR: 2.07, 95% CI: 1.34–3.19), preexisting radiation-induced pneumonitis (OR: 3.62, 95% CI: 1.53–8.58), preexisting respiratory disease (OR: 2.43, 95% CI: 1.45–4.07), preexisting interstitial lung disease (OR: 5.78, 95% CI: 3.08–10.85), preexisting ground glass attenuation (OR: 11.48, 95% CI: 1.13–116.74), preexisting honeycombing (OR: 6.11, 95% CI: 2.37–15.79), preexisting pulmonary emphysema (OR: 2.72, 95% CI: 1.00–7.36), use of pembrolizumab (OR: 2.89, 95% CI: 1.56–5.35, <i>I</i><sup>2</sup> = 0%), high PD-L1 expression (OR: 3.59, 95% CI: 1.23–10.50), and hypoalbuminemia (OR: 0.3, 95% CI: 0.14–0.64). When including the crude ORs, smoking history (OR: 1.39, 95% CI: 1.14–1.71), neutrophil-lymphocyte ratio (OR: 1.04, 95% CI: 1.01–1.08), and c-reactive protein (OR: 1.08, 95% CI: 1.01–1.16) were also risk factors for CIP. <b><i>Conclusion:</i></b> Histological characteristics, specific previous lung diseases and treatment history, treatment regimen, PD-L1 expression level, and serological biomarkers are all closely associated with the development of CIP. These findings would be useful for oncologists to optimize the appropriate options of ICIs and close monitoring during immunotherapy treatments, particularly for patients identified as having a higher risk for CIP.
DOI: 10.6084/m9.figshare.21118888.v1
title: Supplementary Material for: Diverse Parental Perspectives of the Social and Educational Needs for Expanding Newborn Screening through Genomic Sequencing

description: <b><i>Objective:</i></b> The aim of this study was to explore the parental views, attitudes, and preferences of expanded newborn screening (NBS) through genomic sequencing. <b><i>Study Design:</i></b> We conducted a semi-structured interview study with English and Spanish speaking mothers who had given birth within the USA in the past 5 years. The interviews explored opinions of expanding NBS, ethical and privacy concerns, and educational and social needs. <b><i>Results:</i></b> All participants were interested in some degree of NBS expansion. However, there were differing opinions about the characteristics of conditions that should be included with less consensus for conditions with low penetrance, those without approved treatment, or onset outside of early childhood. All parents endorsed potential medical utility but also nonmedical utility as a motivating factor including being able to prepare and not being surprised by health issues as they occurred. Most felt that it was important to have some choice about the conditions screened, and many expressed the importance of proper education to make an informed choice and a desire to receive this education in the prenatal period. Responses to the type of education and information needed to make an informed decision varied. <b><i>Conclusions:</i></b> Parents anticipate value in expanded NBS through genomic sequencing both for medical and nonmedical/personal utility. In order to successfully implement expanded NBS, prospective parents need more and earlier education about the process. These needs may differ by language and culture. Information needs to be easily accessible and to be curated by appropriate experts and stakeholders, including parents representative of the diversity of the USA.
DOI: 10.6084/m9.figshare.19791469
title: Clark et al Coral trout thermoreg data.xlsx

description: Data set for Clark et al. "Behavioural temperature regulation is a low priority in a coral reef fish (Plectropomus leopardus): insights from a novel behavioural thermoregulation system"
DOI: 10.17028/rd.lboro.21118861
title: Supplementary information files for A susceptibility putative haplotype within NLRP3 inflammasome gene influences ischaemic stroke risk in the population of Punjab, India

description: Supplementary information files for article A<strong> </strong>susceptibility putative haplotype within NLRP3 inflammasome gene influences ischaemic stroke risk in the population of Punjab, India Despite strong genetic implications of NLRP3 inflammasome, its examination as genetic determinant of ischaemic stroke (IS) remains to be done in Punjab, which has been investigated in this study. In this case control study, 400 subjects (200 IS patients, 200 stroke free controls) were included. Contributions of 5 single nucleotide polymorphisms (SNPs) including a functional SNP within NLRP3 gene (rs10754558, rs4612666, rs2027432, rs3738488 and rs1539019) for the risk of IS were investigated through genetic models after correcting the effect of significant variables. Plasma levels of three pro-inflammatory markers, that is, C-reactive protein (CRP), interleukin-1beta (IL-1β) and interleukin-18 (IL-18) were measured by enzyme-linked immunosorbent assays (ELISA). Minor alleles of 3 out of 5 SNPs (rs10754558, rs4612666 and rs1539019) exhibited association with IS risk in additive, recessive and multiplicative models. Multivariable regression analysis confirmed that higher levels of systolic blood pressure (<em>β</em> ± SE: 1.42 ± 0.57, <em>p</em> = .013), CRP (<em>β</em> ± SE: 1.22 ± 0.41, <em>p</em> = .003), IL-1β (<em>β</em> ± SE: 1.78 ± 0.88, <em>p</em> = .043) and IL-18 (<em>β</em> ± SE: 1.13 ± 0.49, <em>p</em> = .021) were independent risk predictors for IS. Haplotype analysis revealed a susceptibility putative haplotype GTGTA, which approximately doubled the IS risk (OR: 1.98, 95% CI: 1.12–3.78, <em>p</em> = .04) in dominant mode after adjusting the effect with confounding variables. This susceptibility putative haplotype GTGTA was significantly associated with increased concentrations of CRP (<em>β</em> = 1.21, <em>p</em> = .014) and IL-1β (<em>β</em> = 1.53, <em>p</em> = .034) in dose-dependent manner (less in carriers of 1 copy than those who had 2 copies of GTGTA). The present study has revealed a susceptibility putative haplotype GTGTA within NLRP3 gene, carriers of which have double the risk of IS by having increased plasma levels of CRP and IL-1β in a dose-dependent manner.
DOI: 10.17028/rd.lboro.21118861.v1
title: Supplementary information files for A susceptibility putative haplotype within NLRP3 inflammasome gene influences ischaemic stroke risk in the population of Punjab, India

description: Supplementary information files for article A<strong> </strong>susceptibility putative haplotype within NLRP3 inflammasome gene influences ischaemic stroke risk in the population of Punjab, India Despite strong genetic implications of NLRP3 inflammasome, its examination as genetic determinant of ischaemic stroke (IS) remains to be done in Punjab, which has been investigated in this study. In this case control study, 400 subjects (200 IS patients, 200 stroke free controls) were included. Contributions of 5 single nucleotide polymorphisms (SNPs) including a functional SNP within NLRP3 gene (rs10754558, rs4612666, rs2027432, rs3738488 and rs1539019) for the risk of IS were investigated through genetic models after correcting the effect of significant variables. Plasma levels of three pro-inflammatory markers, that is, C-reactive protein (CRP), interleukin-1beta (IL-1β) and interleukin-18 (IL-18) were measured by enzyme-linked immunosorbent assays (ELISA). Minor alleles of 3 out of 5 SNPs (rs10754558, rs4612666 and rs1539019) exhibited association with IS risk in additive, recessive and multiplicative models. Multivariable regression analysis confirmed that higher levels of systolic blood pressure (<em>β</em> ± SE: 1.42 ± 0.57, <em>p</em> = .013), CRP (<em>β</em> ± SE: 1.22 ± 0.41, <em>p</em> = .003), IL-1β (<em>β</em> ± SE: 1.78 ± 0.88, <em>p</em> = .043) and IL-18 (<em>β</em> ± SE: 1.13 ± 0.49, <em>p</em> = .021) were independent risk predictors for IS. Haplotype analysis revealed a susceptibility putative haplotype GTGTA, which approximately doubled the IS risk (OR: 1.98, 95% CI: 1.12–3.78, <em>p</em> = .04) in dominant mode after adjusting the effect with confounding variables. This susceptibility putative haplotype GTGTA was significantly associated with increased concentrations of CRP (<em>β</em> = 1.21, <em>p</em> = .014) and IL-1β (<em>β</em> = 1.53, <em>p</em> = .034) in dose-dependent manner (less in carriers of 1 copy than those who had 2 copies of GTGTA). The present study has revealed a susceptibility putative haplotype GTGTA within NLRP3 gene, carriers of which have double the risk of IS by having increased plasma levels of CRP and IL-1β in a dose-dependent manner.
DOI: 10.34740/kaggle/dsv/4207370
title: YouTube Daily
DOI: 10.6084/m9.figshare.20705728
title: Effect of spermidine on larval and silk gland weight of 5th instar Bombyx mori larvae

description: The above data shows the weight of larvae and silk gland of day 5 of 5th instar larval stage of <em>Bombyx. mori</em> after heat shock with different temperatures.
DOI: 10.6084/m9.figshare.20705728.v4
title: Effect of spermidine on larval and silk gland weight of 5th instar Bombyx mori larvae

description: The above data shows the weight of larvae and silk gland of day 5 of 5th instar larval stage of <em>Bombyx. mori</em> after heat shock with different temperatures.
DOI: 10.6084/m9.figshare.20708278
title: Effect of spermidine on total protein and carbohydrate content in whole silk worm

description: The above data shows the presence of total protein and carbohydate content in whoe 5<sup>th</sup> instar spermidine fed silk worm larvae after heat shock treatment.
DOI: 10.6084/m9.figshare.20705728.v3
title: Effect of spermidine on larval and silk gland weight of 5th instar Bombyx mori larvae

description: The above data shows the weight of larvae and silk gland of day 5 of 5th instar larval stage of <em>Bombyx. mori</em> after heat shock with different temperatures.
DOI: 10.6084/m9.figshare.20708278.v2
title: Effect of spermidine on total protein and carbohydrate content in whole silk worm

description: The above data shows the presence of total protein and carbohydate content in whoe 5<sup>th</sup> instar spermidine fed silk worm larvae after heat shock treatment.
DOI: 10.6084/m9.figshare.20708866
title: Effect of spermidine on antioxidant potential of 5th instar Bombyx mori larave

description: The above data shows the effect of spermidine on antioxidant potential of 5<sup>th</sup> instar heat shocked <em>Bombyx mori</em> larvae.
DOI: 10.6084/m9.figshare.20708866.v3
title: Effect of spermidine on antioxidant potential of 5th instar Bombyx mori larave

description: The above data shows the effect of spermidine on antioxidant potential of 5<sup>th</sup> instar heat shocked <em>Bombyx mori</em> larvae.
DOI: 10.6084/m9.figshare.20708866.v2
title: The effect of spermidine on antioxidant potential of 5th instar Bombyx mori larave

description: The above data shows the effect of spermidine on antioxidant potential of 5<sup>th</sup> instar heat shocked <em>Bombyx mori</em> larvae.
DOI: 10.5281/zenodo.6597972
title: RETALT2 – AERODYNAMIC DATA BASE 2.0

description: The excel file contains the Aerodynamic Data Base for the RETALT2 configuration. The pdf file contains the necessary information to use this data base
DOI: 10.5281/zenodo.6597971
title: RETALT2 – AERODYNAMIC DATA BASE 2.0

description: The excel file contains the Aerodynamic Data Base for the RETALT2 configuration. The pdf file contains the necessary information to use this data base. The CFD Excel sheet contains the results of CFD simulations for different conditions and control surface deflections
DOI: 10.5281/zenodo.7081540
title: RETALT2 – AERODYNAMIC DATA BASE 2.0

description: The excel file contains the Aerodynamic Data Base for the RETALT2 configuration. The pdf file contains the necessary information to use this data base. The CFD Excel sheet contains the results of CFD simulations for different conditions and control surface deflections
DOI: 10.6084/m9.figshare.12163569
title: Anger makes fake news viral online

description: The data set is used in our working paper entitled "Anger makes fake news viral online", which can be cited as: <br> Yuwei Chuai and <strong>Jichang Zhao*</strong>. Anger Can Make Fake News Viral Online. <em><strong>Frontiers in Physics</strong></em>, 10:970174, 2022, doi:10.3389/fphy.2022.970174. <br> 1. Details of the data set and code can be found in Readme.png. <br> 2. Any issues please feel free to contact jichang@buaa.edu.cn for information.
DOI: 10.34943/d68320b6-4859-466f-aa2c-baaabdbdfbf7
title: Cambridge Bay Turbidity Meter Deployed 2022-09-12

description: The WET Labs ECO-NTUS 319 was deployed on 2022-09-12 at Cambridge Bay. Cambridge Bay is located on Victoria Island in the Kitikmeot Region of Nunavut, Canada. This device is a Turbidity Meter. Turbidity meters are sensors that detect scattered light from suspended particles in water. The amount of scattered light that reaches the detector is proportional to the turbidity or particle concentration in the water. It was deployed on a fixed platform. Data from this deployment were archived and made available through Ocean Networks Canada's Oceans 3.0 digital infrastructure, with quality assurance and derived data products following established practices.
DOI: 10.34943/0632c5a5-b88e-4818-babd-f372aee05942
title: Cambridge Bay Fluorometer Deployed 2022-09-12

description: The WET Labs ECO FLRT 6106 was deployed on 2022-09-12 at Cambridge Bay. Cambridge Bay is located on Victoria Island in the Kitikmeot Region of Nunavut, Canada. This device is a Fluorometer. Fluorometers measure the amount of stimulated electromagnetic radiation (fluorescence) produced by pulses of electromagnetic radiation emitted into the water column. It was deployed on a fixed platform. Data from this deployment were archived and made available through Ocean Networks Canada's Oceans 3.0 digital infrastructure, with quality assurance and derived data products following established practices.
DOI: 10.6084/m9.figshare.20227263
title: Fagus orientalis_additional files

description: Additional files for the genetic pattern of Oriental beech. <br> <br>
DOI: 10.6084/m9.figshare.20227263.v1
title: Fagus orientalis_additional files

description: Additional files for the genetic pattern of Oriental beech. <br> <br>
DOI: 10.34943/528287e9-ac73-491f-8ad1-6f7a4b8c1b6d
title: Cambridge Bay Radiometer Deployed 2022-09-12

description: The WET Labs ECO-PARS (S/N 459) was deployed on 2022-09-12 at Cambridge Bay. Cambridge Bay is located on Victoria Island in the Kitikmeot Region of Nunavut, Canada. This device is a Radiometer. Radiometers collect measurements of electromagnetic radiation in the ocean environment. It was deployed on a fixed platform. Data from this deployment were archived and made available through Ocean Networks Canada's Oceans 3.0 digital infrastructure, with quality assurance and derived data products following established practices.
DOI: 10.34943/646932d2-2c9a-4d45-b098-831ce2829037
title: Cambridge Bay Carbon Dioxide Sensor Deployed 2022-09-12

description: The Pro-Oceanus CO2-Pro CV (SN 36-314-75) was deployed on 2022-09-12 at Cambridge Bay. Cambridge Bay is located on Victoria Island in the Kitikmeot Region of Nunavut, Canada. This device is a Carbon Dioxide Sensor. Carbon Dioxide sensors monitor CO2 levels in the ocean. CO2 sensors measure the partial pressure, or the concentration of dissolved CO2 in seawater by a variety of techniques. It was deployed on a fixed platform. Data from this deployment were archived and made available through Ocean Networks Canada's Oceans 3.0 digital infrastructure, with quality assurance and derived data products following established practices.
DOI: 10.34943/ccfdd35d-0b83-48a5-a48d-8c0865471581
title: Cambridge Bay Conductivity Temperature Depth Deployed 2022-09-12

description: The Sea-Bird SeaCAT SBE19plus V2 7769 was deployed on 2022-09-12 at Cambridge Bay. Cambridge Bay is located on Victoria Island in the Kitikmeot Region of Nunavut, Canada. This device is a Conductivity Temperature Depth. Conductivity Temperature Depth (CTD) is an instrument package that contains sensors for measuring the conductivity, temperature, and pressure of seawater. Salinity, sound velocity, depth and density are variables that can be derived from sensor measurements. CTDs can carry additional instruments and sensors such as oxygen sensors, turbidity sensors and fluorometers. It was deployed on a fixed platform. Data from this deployment were archived and made available through Ocean Networks Canada's Oceans 3.0 digital infrastructure, with quality assurance and derived data products following established practices.
DOI: 10.34943/c50b987f-66a1-4b34-9eb9-60ec04ceafdf
title: Cambridge Bay Oxygen Sensor Deployed 2022-09-12

description: The Sea-Bird SBE 63 Dissolved Oxygen Sensor 631500 was deployed on 2022-09-12 at Cambridge Bay. Cambridge Bay is located on Victoria Island in the Kitikmeot Region of Nunavut, Canada. This device is a Oxygen Sensor. Oxygen sensors measure dissolved oxygen concentration in seawater. It was deployed on a fixed platform. Data from this deployment were archived and made available through Ocean Networks Canada's Oceans 3.0 digital infrastructure, with quality assurance and derived data products following established practices.
DOI: 10.6084/m9.figshare.21119203
title: Figure 4. Spatially Resolved Temperature Measurements

description: Dataset for figure 4 which is the demonstration of spatially resolved temperature measurements. Each of the 480 sensors take temperature measurements which are saved in CSV files, one CSV file per frame per day.
DOI: 10.6084/m9.figshare.21119203.v1
title: Figure 4. Spatially Resolved Temperature Measurements

description: Dataset for figure 4 which is the demonstration of spatially resolved temperature measurements. Each of the 480 sensors take temperature measurements which are saved in CSV files, one CSV file per frame per day.
DOI: 10.6084/m9.figshare.21119188
title: Figure 2 - Histogram. Spatially Resolved Temperature Measurmeents

description: Dataset collected from the Spatially Resolved Temperature Measurement system. All 480 sensors collect data which have been stored in multiple CSV files, one file per frame, per day.
DOI: 10.6084/m9.figshare.21119188.v1
title: Figure 2 - Histogram. Spatially Resolved Temperature Measurmeents

description: Dataset collected from the Spatially Resolved Temperature Measurement system. All 480 sensors collect data which have been stored in multiple CSV files, one file per frame, per day.
DOI: 10.14272/tucalalayjtwfb-uhfffaoysa-n.1
title: N-benzyl-2,3,4,5,6-pentafluoro-N-(2-(phenylethynyl)phenyl)benzamide
title: InChI=1S/C28H16F5NO/c29-23-22(24(30)26(32)27(33)25(23)31)28(35)34(17-19-11-5-2-6-12-19)21-14-8-7-13-20(21)16-15-18-9-3-1-4-10-18/h1-14H,17H2

description: This dataset contains experimental data from a sample (InChI=1S/C28H16F5NO/c29-23-22(24(30)26(32)27(33)25(23)31)28(35)34(17-19-11-5-2-6-12-19)21-14-8-7-13-20(21)16-15-18-9-3-1-4-10-18/h1-14H,17H2). The datasets from the following experiments are available: 1H nuclear magnetic resonance spectroscopy (1H NMR) 13C nuclear magnetic resonance spectroscopy (13C NMR) distortionless enhancement with polarization transfer (DEPT) distortionless enhancement with polarization transfer (DEPT) 1H--13C heteronuclear single quantum coherence (1H-13C HSQC) 1H--13C heteronuclear multiple bond coherence (13C-1H HMBC) 19F nuclear magnetic resonance spectroscopy (19F NMR) mass spectrometry (MS) infrared absorption spectroscopy (IR) ultraviolet-visible spectrophotometry (UV-VIS)
DOI: 10.14272/tucalalayjtwfb-uhfffaoysa-n/chmo0000596
title: distortionless enhancement with polarization transfer (DEPT) ()
title: InChI=1S/C28H16F5NO/c29-23-22(24(30)26(32)27(33)25(23)31)28(35)34(17-19-11-5-2-6-12-19)21-14-8-7-13-20(21)16-15-18-9-3-1-4-10-18/h1-14H,17H2

description: dataset for distortionless enhancement with polarization transfer (DEPT)
DOI: 10.14272/tucalalayjtwfb-uhfffaoysa-n/chmo0001146
title: 1H--13C heteronuclear single quantum coherence (1H-13C HSQC) ()
title: InChI=1S/C28H16F5NO/c29-23-22(24(30)26(32)27(33)25(23)31)28(35)34(17-19-11-5-2-6-12-19)21-14-8-7-13-20(21)16-15-18-9-3-1-4-10-18/h1-14H,17H2

description: dataset for 1H--13C heteronuclear single quantum coherence (1H-13C HSQC)
DOI: 10.14272/tucalalayjtwfb-uhfffaoysa-n/chmo0000597
title: 19F nuclear magnetic resonance spectroscopy (19F NMR) ()
title: InChI=1S/C28H16F5NO/c29-23-22(24(30)26(32)27(33)25(23)31)28(35)34(17-19-11-5-2-6-12-19)21-14-8-7-13-20(21)16-15-18-9-3-1-4-10-18/h1-14H,17H2

description: dataset for 19F nuclear magnetic resonance spectroscopy (19F NMR) 19F NMR (376 MHz, CDCl3, ppm) δ = -136.95 (d, J = 21.8 Hz), -138.14 (d, J = 24.5 Hz), -152.20 (t, J = 20.4 Hz), [(-159.99)–(-160.13) (m)], [(-161.36)–(-161.51) (m)].